Myelodysplasia News and Research

RSS
Combined therapy for acute leukemia shows promising results

Combined therapy for acute leukemia shows promising results

Discovery of new syndrome associated with severe congenital neutropenia

Discovery of new syndrome associated with severe congenital neutropenia

FDA accepts Zevalin supplemental biologics license application

FDA accepts Zevalin supplemental biologics license application

FDA approves GSK's Promacta (Eltrombopag)

FDA approves GSK's Promacta (Eltrombopag)

FDA approves Nplate (romiplostim), first bone marrow stimulator for chronic immune thrombocytopenic purpura

FDA approves Nplate (romiplostim), first bone marrow stimulator for chronic immune thrombocytopenic purpura

Genetic mutations and cellular modifications may provide clues to the associations between slight genetic abnormalities and often fatal diseases

Genetic mutations and cellular modifications may provide clues to the associations between slight genetic abnormalities and often fatal diseases

Data from phase II study of Trisenox (arsenic trioxide) injection in myelodysplasia

Data from phase II study of Trisenox (arsenic trioxide) injection in myelodysplasia

Impaired cognitive and motor function following stem cell transplantation for severe blood disorders can improve

Impaired cognitive and motor function following stem cell transplantation for severe blood disorders can improve

Scientists lead fight against blood cancers

Scientists lead fight against blood cancers

Guidelines for determining the best possible time to receive bone marrow transplants

Guidelines for determining the best possible time to receive bone marrow transplants

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.